An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes

J Paediatr Child Health. 2013 Aug;49(8):614-23. doi: 10.1111/jpc.12221. Epub 2013 May 7.

Abstract

This is the second of two updates on Kawasaki disease. The first review focused on epidemiology and aetio-pathogenesis. Here, we review the clinical features and diagnosis of Kawasaki disease, as well as recent evidence on treatment, follow-up and cardiovascular outcomes.

Keywords: Kawasaki disease; diagnosis; outcome; treatment.

Publication types

  • Review

MeSH terms

  • Aspirin / therapeutic use
  • Biomarkers / analysis
  • Cardiac Catheterization
  • Echocardiography
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Mucocutaneous Lymph Node Syndrome / diagnosis*
  • Mucocutaneous Lymph Node Syndrome / drug therapy*
  • Mucocutaneous Lymph Node Syndrome / surgery
  • Steroids / therapeutic use
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Biomarkers
  • Immunoglobulins, Intravenous
  • Steroids
  • Tumor Necrosis Factor-alpha
  • Aspirin